Bone Health & Osteoporosis Prevention

Bone Health & Osteoporosis Prevention: The Longevity Case for Building Stronger Bones Starting Now

In This Article

• Bone Biology: Why Density Declines with Age
• The Fracture-Mortality Connection
• Exercise: The Most Powerful Bone-Building Intervention
• The Bone-Building Nutrient Stack
• Hormones, HRT & Bone Health
• What Silently Destroys Your Bones
• Feet, Stress Fractures & the Podiatry-Bone Health Connection
• Frequently Asked Questions

In three decades of clinical practice, I’ve held the X-rays of too many osteoporotic fractures that could have been prevented. I’ve counseled patients after hip replacements they needed because of falls from bones that were depleted over decades of inadequate nutrients and insufficient mechanical loading. I’ve treated stress fractures in runners and athletes whose bones, despite their fitness, were being silently undermined by low vitamin D, inadequate calcium, or disordered eating. And as a podiatrist, I see the downstream consequences of bone loss — foot fractures from minimal trauma, Charcot foot in neuropathic patients, and post-surgical non-union in bones too demineralized to heal.

Bone health is not a women’s issue. It is not an issue that starts at 60. And it is not an issue that primarily gets managed with medications. It is a lifelong investment in the structural scaffolding that determines whether you can move, function, and maintain independence into your 80s and 90s. Let’s build that foundation.

Bone Biology: Why Density Declines with Age

Bone is not static — it is continuously remodeled by two cell types working in opposition: osteoblasts (bone builders) and osteoclasts (bone dissolvers). In youth, osteoblast activity exceeds osteoclast activity — bones accumulate mass until peak bone density is reached at approximately age 25–35. After that, the balance gradually shifts toward resorption. By age 40, most adults lose about 0.5–1% of bone mineral density (BMD) per year. After menopause in women, estrogen’s protective effect on bone is lost and the rate accelerates to 2–3% per year for 5–7 years. In men, declining testosterone in the 50s and 60s produces a more gradual but equally real BMD decline of 1–1.5% per year.

The RANK-RANKL-OPG Pathway

The molecular control of bone remodeling centers on the RANK/RANKL/OPG axis. RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand) activates osteoclasts; OPG (osteoprotegerin) is a decoy receptor that inhibits RANKL and protects bone. Estrogen, testosterone, and physical loading all increase OPG production and decrease RANKL expression — explaining why all three protect bone. Pro-inflammatory cytokines (particularly IL-1, TNF-alpha, and IL-6 from the SASP of senescent cells and from dysbiotic gut-derived LPS) increase RANKL and decrease OPG — explaining why systemic inflammation from any source accelerates bone loss. This mechanistic connection means that reducing inflammaging — via gut health, sleep, stress management, and exercise — is also a bone protection strategy.

The Fracture-Mortality Connection

Hip fracture is a medical emergency with mortality consequences that rival many cancers. A 2022 meta-analysis found that one-year mortality after hip fracture was 20–30% in older adults — higher in men (32%) than women (17%), and higher with each decade of age. The causes of post-fracture mortality are multifactorial: surgical complications, hospital-acquired infections (pneumonia, PE, UTIs), deconditioning from immobility, loss of independent living causing depression and functional decline, and the underlying frailty that allowed the fall in the first place. Vertebral compression fractures — often “silent” (occurring with minimal trauma and without immediate severe pain) — cause progressive kyphosis, reduced lung capacity, chronic back pain, and a 2–3x increase in subsequent fracture risk. The cumulative burden of fractures on longevity is dramatic: each fragility fracture approximately doubles the risk of the next one.

Fall Prevention is Bone Longevity

A bone that never fractures protects longevity regardless of its T-score. Fall prevention is therefore as important as bone density optimization. The modifiable fall risk factors include: muscle weakness (sarcopenia — addressed in the protein article), balance impairment (proprioception declines with age, restorable with balance training), medication-induced unsteadiness (sedatives, anticholinergics, blood pressure medications, and polypharmacy are major culprits), vision impairment, and foot/ankle problems — which is where I have direct clinical leverage as a podiatrist. Foot deformities, ankle instability, peripheral neuropathy, and inappropriate footwear are all modifiable fall risk factors that are frequently undertreated in older adults.

Exercise: The Most Powerful Bone-Building Intervention

Bone responds to mechanical loading through a process called mechanotransduction: physical force deforms bone tissue → osteocytes sense the deformation via canalicular fluid flow → they signal osteoblasts to build more bone at sites of mechanical stress. This is Wolff’s Law — bone adapts its structure to the forces it experiences. The clinical implication: only exercise that loads the skeleton stimulates bone building. Swimming and cycling, while excellent for cardiovascular health, provide minimal bone-building stimulus because they are non-weight-bearing (water and bike support the weight, not the bones). Walking provides moderate stimulus. Resistance training (weights, bands, loaded carries) and high-impact activities (jumping, running, dancing) provide the strongest osteogenic signals.

The Resistance Training + Bone Protocol

A 2022 systematic review and meta-analysis in Osteoporosis International of 43 randomized trials found that progressive resistance training increased lumbar spine BMD by an average of 1.2% and femoral neck BMD by 0.8% per year in postmenopausal women — meaningfully reversing the 2–3% annual loss from menopause-related bone turnover acceleration. The most effective protocols: compound, multi-joint movements (squats, deadlifts, step-ups) at 70–85% of 1RM, performed 2–3x per week, with progressive overload. Heavy resistance training is dramatically superior to light-resistance, high-rep training for bone density — the high mechanical strain signal is what drives osteoblast activation, and that requires substantial load. For older adults concerned about injury: properly supervised progressive loading programs, starting conservatively and building over 6–12 months, are safe and effective. The risk of not loading bones is far greater than the risk of properly supervised resistance training at any age.

Jump Training and Bone: The Underrated Protocol

High-impact activities — jumping, running, stair climbing — generate peak ground reaction forces of 3–5x body weight at the femoral neck and spine, providing very high osteogenic stimulus per unit time. A remarkably low dose is effective: a 2015 study in the American Journal of Health Promotion found that just 10–20 jumps per day (three sessions per week), done at maximum effort, significantly increased femoral neck BMD in premenopausal women over 4 months. The stimulating stimulus is the impact rate of loading (how fast the force rises) rather than the total force magnitude — which is why jogging is more osteogenic per step than slow walking. For patients with osteoporosis or severe osteopenia who cannot safely do high-impact loading, weighted step-ups and box squats provide similar mechanical strain to the femoral neck without impact forces.

The Bone-Building Nutrient Stack

Exercise provides the mechanical signal; nutrients provide the raw materials. The key nutrients for bone health — and their evidence-based targets — are more nuanced than the simple “take calcium and vitamin D” advice most patients receive.

Calcium: The Right Dose and Form

Calcium is the dominant mineral in bone (approximately 99% of the body’s calcium is in bone), but supplemental calcium has generated controversy after several meta-analyses suggested modest cardiovascular risk from calcium supplements. The current evidence favors: (1) Getting calcium primarily from food (dairy, sardines, leafy greens, fortified foods) targets 1,000–1,200 mg/day for adults over 50; (2) If supplementing, calcium citrate is preferred over calcium carbonate — citrate absorbs without requiring stomach acid (critical for the many older adults taking PPIs), while carbonate requires an acid environment; (3) Doses above 500 mg at a time are not fully absorbed — split doses throughout the day; (4) The cardiovascular concern was primarily from high-dose supplementation in calcium-replete populations — the risk is not seen in populations with dietary calcium insufficiency. Food-first calcium strategy, with targeted supplementation only for those with documented dietary insufficiency, is the optimal approach.

Vitamin D3 + K2: The Essential Pairing

Vitamin D3 is required for intestinal calcium absorption — without adequate D3, even sufficient dietary calcium is poorly absorbed. Target serum 25-OH vitamin D of 50–80 ng/mL (125–200 nmol/L) for optimal bone and immune function; most longevity physicians consider 40–60 ng/mL the minimum protective range. Achieving this in Michigan (where I practice) requires supplementation of 3,000–5,000 IU D3 daily for most adults, with periodic 25-OH vitamin D testing to confirm levels. Vitamin K2 (specifically MK-7 form, 100–200 mcg/day) is the critical partner to D3 that most calcium discussions neglect: K2 activates osteocalcin (which incorporates calcium into bone matrix) and activates matrix Gla protein (which prevents calcium from depositing in arteries instead of bone). Without adequate K2, supplemental D3 and calcium can paradoxically increase vascular calcification — precisely the cardiovascular concern raised in calcium supplement trials. D3 + K2 together direct calcium to bones and away from arteries.

Magnesium, Collagen, and the Supporting Cast

Magnesium is required for over 300 enzymatic reactions including bone mineralization, and approximately 60% of the body’s magnesium is stored in bone. Low serum magnesium is independently associated with lower BMD and higher fracture risk. Target: 320–420 mg/day from food and supplement; magnesium glycinate or malate are well-absorbed forms that cause less GI upset than magnesium oxide. Collagen is the organic framework of bone (approximately 35% of bone mass by weight), providing the flexible tensile strength that prevents bones from being brittle even as they mineralize. Hydrolyzed collagen peptides (10–15 g/day) + vitamin C provide the building blocks for both bone collagen and joint cartilage synthesis. A 2018 study in Nutrients found that 5 g/day of specific collagen peptides significantly increased BMD at the spine and femoral neck in postmenopausal women over 12 months compared to placebo. Boron (3–6 mg/day from food or supplement) increases estrogen and testosterone availability and reduces urinary calcium excretion; epidemiological data consistently links higher boron intake to lower osteoporosis rates.

Hormones, HRT & Bone Health

Hormonal optimization is one of the most powerful and most underutilized bone protection tools available. The evidence here is compelling and has been repeatedly vindicated by recent data.

Estrogen and Bone: The Women’s Health Initiative Reconsidered

The 2002 Women’s Health Initiative (WHI) study, which reported elevated breast cancer and cardiovascular risk from combined estrogen-progestin HRT, caused a massive withdrawal of hormone therapy that persisted for 15+ years — during which time millions of women were denied a therapy that powerfully protects bone, reduces hot flashes, and appears to reduce dementia risk when started early. The subsequent reanalysis has largely vindicated early hormone therapy: the risks in the WHI were primarily seen in women who started HRT over 10 years after menopause (the “timing hypothesis”). Women who start HRT within 10 years of menopause onset — when bone loss is most rapid — have substantially lower cardiovascular and dementia risk and significant bone protection. Current evidence supports that estrogen is the most effective single intervention for preventing postmenopausal bone loss, and bioidentical hormone therapy (transdermal estradiol + micronized progesterone) has a better safety profile than the oral synthetic hormones used in the WHI. This is a nuanced clinical decision requiring individualized risk-benefit assessment with a physician familiar with the current evidence.

Testosterone and Male Bone Health

Male osteoporosis is underdiagnosed and undertreated — men account for approximately 20–25% of osteoporotic fractures but receive far fewer DXA scans and far less treatment than women with equivalent fracture risk. Testosterone protects male bone directly (via androgen receptors on osteoblasts and osteoclasts) and indirectly (by aromatizing to estrogen, which also protects male bone — men with aromatase deficiency develop severe osteoporosis). As testosterone declines in men’s 50s–60s, bone loss accelerates. Testosterone replacement therapy in hypogonadal men (testosterone below 300 ng/dL by current guidelines, though many longevity physicians use a symptom-based threshold) consistently increases BMD at the hip and spine. The testosterone-bone connection is direct enough that hypogonadism is a secondary cause of osteoporosis that should be evaluated in any man diagnosed with unexpectedly low bone density.

What Silently Destroys Your Bones

• Glucocorticoids (prednisone, cortisol) — the most potent iatrogenic cause of osteoporosis; 5 mg/day of prednisone for ≥3 months significantly accelerates bone loss via RANK-RANKL pathway activation and direct osteoblast inhibition. Anyone on chronic steroids needs bisphosphonate or other bone-protective therapy concurrent with the steroid.
• Proton pump inhibitors (PPIs) — chronic PPI use reduces gastric acid needed to absorb calcium carbonate and appears to directly reduce osteoclast activity through unclear mechanisms; meta-analyses show 30–40% higher fracture risk with chronic PPI use. The proliferation of chronic, unnecessary PPI use is a public health bone crisis.
• Excess alcohol — more than 2 drinks/day directly inhibits osteoblast function, increases cortisol (which activates osteoclasts), and reduces vitamin D activation in the liver.
• Smoking — nicotine directly kills osteoblasts, reduces estrogen levels, impairs intestinal calcium absorption, and reduces blood supply to bone; smokers have 25–40% lower BMD than non-smokers by age 70.
• Chronic inflammation — SASP from senescent cells, LPS from leaky gut, and uncontrolled inflammatory conditions all activate osteoclasts via RANKL overexpression. Addressing inflammaging is a bone protection strategy.
• Low body weight / disordered eating — particularly low-fat diets (fat is required for vitamin D and K2 absorption), very low-calorie restriction, and disordered eating with inadequate nutritional intake are among the most common causes of premature osteoporosis in athletic women (the “female athlete triad”: low energy availability + menstrual irregularity + low BMD).

Feet, Stress Fractures & the Podiatry-Bone Health Connection

The foot contains 26 bones — more than any other body part per unit volume — and bears cumulative forces of 2–3x body weight during walking and up to 7x during running. Foot bones are among the most common sites of stress fractures, and stress fractures in the foot are a red flag for systemic bone insufficiency that is frequently missed.

When I see a stress fracture in a runner — particularly a metatarsal or navicular stress fracture — my first question is not “did they train too much?” (which is rarely the only factor). It is “what is their vitamin D level, and when did they last have a DXA scan?” Stress fractures in recreational runners who are not overtrained frequently reveal underlying osteopenia or frank osteoporosis that the patient had no idea they had. The second metatarsal shaft stress fracture in a 42-year-old female runner with a normal BMI is a sentinel event that warrants full metabolic bone evaluation.

Charcot neuropathic arthropathy — the severe foot and ankle bone destruction seen in patients with advanced diabetes and neuropathy — has a bone quality component as well as a neurological one. Diabetic patients have consistently lower BMD than matched non-diabetic controls despite often having higher BMI (fat mass does not protect bones the way muscle mass does), and the poorly mineralized bone in diabetes fails catastrophically under mechanical loading when peripheral neuropathy removes the protective pain signal. Managing bone health in my diabetic patients — aggressive vitamin D repletion, resistance training, optimal glycemic control — is part of Charcot prevention as much as sensory neuropathy management.

Frequently Asked Questions About Bone Health & Longevity

Can I actually build bone density after 60?

Yes — bone building is possible at any age with the right interventions. A 2022 meta-analysis of resistance training trials in adults over 60 found average BMD increases of 1–2% per year at the hip and spine with progressive loading programs. Individual response varies — those with the lowest baseline BMD tend to show the largest relative improvements. The more realistic framing for older adults: the primary goal after 60 shifts from “building peak density” to “slowing loss and maintaining structural integrity.” Even holding bone density steady (zero loss per year) while your peers lose 1–2% per year creates a compounding advantage over decades. Bisphosphonate medications (alendronate, risedronate) in patients with clinical osteoporosis reduce fracture risk by 30–50% and are underused relative to their benefit-risk ratio — particularly in high-risk patients who are not candidates for hormone therapy.

What vitamin D level should I target for bone health?

The conventional “sufficient” threshold is 20 ng/mL (50 nmol/L), but longevity-focused clinicians typically target 50–80 ng/mL (125–200 nmol/L) for bone protection, immune function, and reduced cancer risk. Below 30 ng/mL, intestinal calcium absorption is measurably impaired and parathyroid hormone (PTH) rises to mobilize calcium from bone — creating a secondary hyperparathyroidism that accelerates resorption. Most adults in northern climates (latitudes above 35°N) cannot achieve adequate D3 from sun exposure alone in winter months regardless of outdoor time. Supplementing 3,000–5,000 IU D3 daily (with vitamin K2 100–200 mcg) raises serum levels appropriately for most people; confirm levels with a 25-OH vitamin D blood test every 6–12 months. Vitamin D toxicity (hypercalcemia) requires levels above 150 ng/mL — not a risk from typical supplementation protocols.

Is dairy necessary for bone health, or can I get enough calcium from plants?

Dairy is not required but is the most efficient dietary calcium source for most people — 1 cup of plain yogurt provides 350–400 mg of highly bioavailable calcium. Plant sources can provide adequate calcium, but require attention to both amount and bioavailability: calcium in spinach and Swiss chard is largely bound by oxalates and poorly absorbed (5–10% vs. 30–35% for dairy); bok choy, kale, and broccoli are low-oxalate and well-absorbed; fortified plant milks approach dairy calcium content but vary significantly by brand. Sardines with bones (350 mg per 3 oz) are the single best non-dairy calcium source with outstanding bioavailability. If you avoid dairy, you can achieve adequate calcium with deliberate food choices, but supplementing 300–500 mg calcium citrate daily as insurance is reasonable for those at elevated fracture risk.

Are foot fractures a sign of osteoporosis?

Stress fractures from routine activity (not high-impact sports) or fractures from minimal trauma (stepping off a curb, turning on uneven ground) are red flags for underlying bone fragility. In my clinical practice, when a patient fractures a metatarsal or other foot bone without significant trauma, I order a metabolic bone panel including: 25-OH vitamin D, PTH, serum calcium, phosphate, alkaline phosphatase, and a DXA scan if not recently done. This workup identifies secondary causes of bone loss (vitamin D deficiency, hyperparathyroidism, malabsorption) in a meaningful proportion of patients who have been attributed to “just bad luck” in falling. A stress fracture diagnosis is an opportunity to intervene on bone health before the hip fracture that comes later.

Do I need medication (bisphosphonates) or can lifestyle prevent osteoporosis?

For most people, lifestyle interventions (exercise, nutrition, hormonal optimization, eliminating bone-depleting medications and habits) can maintain bone density in the osteopenic range (T-score -1 to -2.5) and prevent progression to osteoporosis (T-score below -2.5). Clinical osteoporosis — particularly with a prior fragility fracture — generally warrants pharmacological intervention because the fracture risk is high enough that lifestyle alone is insufficient. Bisphosphonates (alendronate 70 mg weekly, risedronate, zoledronic acid annually IV) reduce vertebral fracture risk by 40–70% and hip fracture risk by 30–40% in clinical trials. The major concerns (osteonecrosis of the jaw and atypical femoral fractures) are real but rare — occurring in approximately 1 per 10,000–100,000 patient-years at oral doses. The fracture-prevention benefit is 100–1,000x higher than these rare risks in most osteoporotic patients. Bisphosphonates are often underprescribed out of exaggerated fear of these rare complications.

The Bottom Line

Sources

• Howe TE, Shea B, Dawson LJ, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews. 2011;7:CD000333. PubMed
• Rozenberg S, Body JJ, Bruyère O, et al. Effects of dairy products consumption on health. Journal of Nutrition, Health & Aging. 2016;20(7):748–758. PubMed
• Konig D, Oesser S, Scharla S, et al. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women. Nutrients. 2018;10(1):97. PubMed
• Cauley JA. Public health impact of osteoporosis. Journals of Gerontology Series A. 2013;68(10):1243–1251. PubMed
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288(3):321–333. PubMed
• Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment. JAMA. 2006;296(24):2927–2938. PubMed

Related Articles

• Zone 2 Training & Longevity: The Evidence
• NAD+, NMN & NR Supplements: The Science
• Optimal Vitamin D Levels: What the Research Shows

Dive Deeper into Longevity

• Environmental Toxins & Longevity
• Purpose, Meaning & Longevity
• Gut Microbiome & Longevity: Bacterial Allies
• Sleep & Longevity